Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label semaphorins. Show all posts
Showing posts with label semaphorins. Show all posts

Friday, November 28, 2025

Trio and CRMP2 regulate axon branching and Semaphorin3A signaling

 You need axon branching, so is your doctor competent in its' use?

Trio and CRMP2 regulate axon branching and Semaphorin3A signaling


Abstract

Trio is a neuronally expressed, Rac1- and RhoA-activating RhoGEF, that is required for neurodevelopment. Mutations affecting the Rac1-activating GEF domain of Trio are associated with profound neurodevelopmental delay and Trio knock-out is embryonic lethal. Although there are studies showing a role for Trio in axon patterning, our understanding of the mechanistic underpinnings of Trio function is incomplete. We have now taken an unbiased approach to identifying the interactome of Trio in embryonic axonal compartments. Using immunoprecipitation-mass spectrometry, we identified the Collapsin Response Mediator Protein 2 (CRMP2) as a robust association partner of growth cone-localized Trio. Like Trio, CRMP2 has a well-known role in shaping the cytoskeleton, particularly during axon patterning. In the current study, we demonstrate Trio preferentially interacts with phosphorylated CRMP2 (pCRMP2) and is recruited by pCRMP2 to limit filopodial motility and axon branching. By introducing a GEF1-ablating disease-related mutation, we further demonstrate that Trio-GEF1 signaling is required for pCRMP2-mediated axon branch suppression. Finally, we show that Semaphorin3A invokes pCRMP2-Trio signaling to limit axon branching in vitro, revealing a developmental role for pCRMP2-Trio signaling.

Tuesday, March 12, 2024

Identification of the growth cone as a probe and driver of neuronal migration in the injured brain

 Didn't your competent?doctor figure out these needs a decade ago?

And of course your competent? doctor six years ago figured out what to do with semaphorins to get you recovered!

Do you prefer your  doctor and hospital incompetence NOT KNOWING? OR NOT DOING?

 Semaphorins and their Signaling Mechanisms January 2018

From there: 

Early studies revealed that semaphorins function as axon guidance molecules,(We need this to have our damaged white matter do the connections needed.)

Identification of the growth cone as a probe and driver of neuronal migration in the injured brain

Abstract

Axonal growth cones mediate axonal guidance and growth regulation. We show that migrating neurons in mice possess a growth cone at the tip of their leading process, similar to that of axons, in terms of the cytoskeletal dynamics and functional responsivity through protein tyrosine phosphatase receptor type sigma (PTPσ). Migrating-neuron growth cones respond to chondroitin sulfate (CS) through PTPσ and collapse, which leads to inhibition of neuronal migration. In the presence of CS, the growth cones can revert to their extended morphology when their leading filopodia interact with heparan sulfate (HS), thus re-enabling neuronal migration. Implantation of an HS-containing biomaterial in the CS-rich injured cortex promotes the extension of the growth cone and improve the migration and regeneration of neurons, thereby enabling functional recovery. Thus, the growth cone of migrating neurons is responsive to extracellular environments and acts as a primary regulator of neuronal migration.

Sunday, October 22, 2023

White Matter Wonders: Re-imagining the Brain’s Silent Majority

 But isn't white matter scanning already available?

FDA grants 510(k) clearance for software to image the brain’s white matter August 2023 

Your doctor needs to know the EXACT OBJECTIVE DAMAGE  to your white matter. Then s/he can propose the correct rehab protocols that fix such damage. That would be the case if there was any competency at all in the stroke medical world.

It is your doctor's responsibility to objectively know the damage to both the gray matter and the white matter in your brain. Without that knowledge your doctor is totally guessing what needs to be done to get you recovered.   Which might explain those doctors who prescribe E.T.(Evaluate and Treat) to the therapists. They know nothing about stroke rehab so they are punting responsibility to the therapists. From this research it seems imperative your doctor knows EXACTLY how to initiate axon pathfinding, neurite outgrowth and dendritic branching through your damaged white matter.

And if your doctor knows nothing about semaphorins you don't have a stroke doctor. Run away.

Semaphorins and their Signaling Mechanisms January 2018

From there: 

Early studies revealed that semaphorins function as axon guidance molecules,(We need this to have our white matter do the connections needed.)

The latest here: 

White Matter Wonders: Re-imagining the Brain’s Silent Majority

Summary: Historically, scientific research has largely focused on the gray matter of the brain, leaving the equally important white matter understudied. However, a recent groundbreaking study has used fMRI to detect significant brain activity in white matter.

When subjects performed tasks, researchers observed increased BOLD signals throughout the white matter.

This discovery challenges conventional beliefs about the brain’s activity and emphasizes the potential importance of white matter in understanding various brain disorders.

Key Facts:

  1. The Vanderbilt team, led by John Gore, Ph.D., utilized fMRI to identify BOLD signals, indicative of brain activity, in the white matter—previously a little-researched area.
  2. When subjects performed tasks during the study, there was a noticeable increase in BOLD signals in the white matter across the entire brain.
  3. Despite the current lack of full understanding about these white matter signals, they’re believed to hold valuable insights, especially since many brain disorders, including epilepsy and multiple sclerosis, disrupt the brain’s “connectivity.”

Source: Vanderbilt University

The human brain is made up of two kinds of matter: the nerve cell bodies (gray matter), which process sensation, control voluntary movement, and enable speech, learning and cognition, and the axons (white matter), which connect cells to each other and project to the rest of the body.

Historically, scientists have concentrated on the gray matter of the cortex, figuring that’s where the action is, while ignoring white matter, even though it makes up half the brain. Researchers at Vanderbilt University are out to change that.

For several years, John Gore, Ph.D., director of the Vanderbilt University Institute of Imaging Science, and his colleagues have used functional magnetic resonance imaging (fMRI) to detect blood oxygenation-level dependent (BOLD) signals, a key marker of brain activity, in white matter.

In their latest paper, published Oct. 12 in the Proceedings of the National Academy of Sciences, the researchers report that when people who are having their brains scanned by fMRI perform a task, like wiggling their fingers, BOLD signals increase in white matter throughout the brain.

“We don’t know what this means,” said the paper’s first author, Kurt Schilling, Ph.D., research assistant professor of Radiology and Radiological Sciences at VUMC. “We just know that something is happening. There truly is a powerful signal in the white matter.”

It is important to pursue this because disorders as diverse as epilepsy and multiple sclerosis disrupt the “connectivity” of the brain, Schilling said. This suggests that something is going on in white matter.

To find out, the researchers will continue to study changes in white matter signals they’ve previously detected in schizophrenia, Alzheimer’s disease and other brain disorders. Through animal studies and tissue analysis, they also hope to determine the biological basis for these changes.

In gray matter, BOLD signals reflect a rise in blood flow (and oxygen) in response to increased nerve cell activity.

Perhaps the axons, or the glial cells that maintain the protective myelin sheath around them, also use more oxygen when the brain is “working.” Or perhaps these signals are somehow related to what’s going on in the gray matter.

But even if nothing biological is going on in white matter, “there’s still something happening here,” Schilling said. “The signal is changing. It’s changing differently in different white matter pathways and it’s in all white matter pathways, which is a unique finding.”

One reason that white matter signals have been understudied is that they have lower energy than gray matter signals, and thus are more difficult to distinguish from the brain’s background “noise.”

The VUMC researchers boosted the signal-to-noise ratio by having the person whose brain was being scanned repeat a visual, verbal or motor task many times to establish a trend and by averaging the signal over many different white matter fiber pathways.

“For 25 or 30 years, we’ve neglected the other half of the brain,” Schilling said. Some researchers not only have ignored white matter signals but have removed them from their reports of brain function.

The Vanderbilt findings suggest that many fMRI studies thus “may not only underestimate the true extent of brain activation, but also … may miss crucial information from the MRI signal,” the researchers concluded.

About this neuroscience research news

Author: Bill Snyder
Source: Vanderbilt University
Contact: Bill Snyder – Vanderbilt University
Image: The image is credited to Neuroscience News

Original Research: Closed access.
“Whole-brain, gray, and white matter time-locked functional signal changes with simple tasks and model-free analysis” by Kurt G. Schilling et al. PNAS

Monday, March 28, 2022

Effect of Particle Size and Surface Charge on Nanoparticles Diffusion in the Brain White Matter

 Now that we might have a way to send drugs to the white matter we should be looking at sending in semaphorins.

Semaphorins and their Signaling Mechanisms January 2018

From there: 

Early studies revealed that semaphorins function as axon guidance molecules,(We need this to have our damaged white matter do the connections needed.)

Effect of Particle Size and Surface Charge on Nanoparticles Diffusion in the Brain White Matter

Abstract

Purpose

Brain disorders have become a serious problem for healthcare worldwide. Nanoparticle-based drugs are one of the emerging therapies and have shown great promise to treat brain diseases. Modifications on particle size and surface charge are two efficient ways to increase the transport efficiency of nanoparticles through brain-blood barrier; however, partly due to the high complexity of brain microstructure and limited visibility of Nanoparticles (NPs), our understanding of how these two modifications can affect the transport of NPs in the brain is insufficient.

Methods

In this study, a framework, which contains a stochastic geometric model of brain white matter (WM) and a mathematical particle tracing model, was developed to investigate the relationship between particle size/surface charge of the NPs and their effective diffusion coefficients (D) in WM.

Results

The predictive capabilities of this method have been validated using published experimental tests. For negatively charged NPs, both particle size and surface charge are positively correlated with D before reaching a size threshold. When Zeta potential (Zp) is less negative than -10 mV, the difference between NPs’ D in WM and pure interstitial fluid (IF) is limited.

Conclusion

A deeper understanding on the relationships between particle size/surface charge of NPs and their D in WM has been obtained. The results from this study and the developed modelling framework provide important tools for the development of nano-drugs and nano-carriers to cure brain diseases.

Introduction

Nanoparticles (NPs), which are characterised by a diameter in the range of a few nanometres, have become a promising drug delivery system for the treatments against various brain disorders, owing to the ability to cross the blood-brain barrier (BBB) [1]. A variety of materials have been applied to fabricate NPs, ranging from natural and synthetic polymers, metals to lipid-based or carbon-based materials. Such a wide selection enables the NPs to be tailored with desired chemical and physical characteristics to fulfil the specific delivery purposes [2]; these include BBB penetration, controlled release, sustainable drug supply and localised delivery [3,4,5], etc.

NP transport in brain tissues is dominated by diffusion [6]. Effective diffusion coefficient (D) is a measure of the rate at which the NPs can spread in the tissue. A high value of D usually indicates a short time window for transport. Several efforts have been made to increase the D of NPs, such as modifying the particle size to obtain a higher ratio of molecular thermal motion to the resistance [7], and charging the NP surface to avoid aggregation and deposition [8, 9]. These means have been adopted to enhance the BBB penetration of NPs [10,11,12]. However, whether these modified NPs with the enhanced BBB penetration also have higher effective Ds in the brain parenchyma cannot be guaranteed, because the anatomical structures of BBB and brain parenchyma are very different.

Some studies have provided insights on the important roles that particle size and surface charge can play on NPs diffusion in the brain parenchyma. For example, by measuring Ds of uncharged NPs in rat brain neocortical regions, Thorne et al. [13] concluded that the width of brain tissue extracellular space (ECS) is about 38~64 nm. And the experimental results also showed the negative correlation between particle size and D of the NPs. However, these results are only applicable for uncharged NPs. Years later, Nance et al. [14] found that NPs as large as 114 nm in diameter were also able to transport inside rat and human brain if they were coated with dense poly(ethylene glycol) (PEG), which charged the NPs by about -5 mV. Moreover, Nance and co-workers also demonstrated that different surface functionalities of polystyrene (PS) [14], poly(lactic-co-glycolic acid) (PLGA) [15], dendrimer [16], and quantum dot [17], which charge these NPs with different Zp and also change their hydraulic diameters, led to different diffusion behaviours of the NPs within the brain parenchyma. In the experiment of Dal et al. [18], where apolipoprotein E4 was adsorbed onto polysorbate 80-stabilized NPs and charged the surface by -10 mV, the brain accumulation of the NPs was also improved by 3 folds compared with unmodified NPs. These experimental investigations highlighted the difference made by surface modification of NPs on their brain diffusion.

Nevertheless, by analysing the experimental data reported in the literature, it is evident that there is a gap in the knowledge about the mutual influence and the possibility to decouple the effect of these two parameters (particle size and surface charge) in order to understand their independent effect. Although we now have known that smaller and negatively charged NPs normally possess higher D than bigger and electroneutral NPs, no study has confirmed if there exist exact thresholds for the two parameters. In addition, it is also not clear if one of these two parameters obliterates the other. For example, it may be less intuitive to judge whether the D will increase or decrease when an end functional group gives a NP a bigger size but more negative Zp. Filling this gap of understanding is important to promote the design efficiency of NPs, but it is not easy to perform by experiments only, because particle size and surface charge always change simultaneously after surface functionalization. Take PEG and COOH, two commonly used end functional groups for NPs, as an example; while PEG nearly does not charge NPs and COOH charges NPs negatively, PEG-coated NPs are generally 10 to 20 nm larger than the COOH-coated NPs [14]. Structural complexity and limited accessibility of brain tissue, difficulties in precise control of NPs’ parameters, and low visibility of NPs [18] also make it less feasible to conduct quantitative studies by experiments. By contrast, mathematical modelling is a good alternative to easily decouple these two parameters and provide insights into the abovementioned concerns.

White matter (WM) acts as a relay station and transmits messages between different parts within the central nervous system [19]. As a result, diseases with white matter, such as Alzheimer's disease and glioblastoma, can critically affect brain function [20]. However, transport of NPs, which is a promising technique to treat these diseases, in WM has not received sufficient attention. In addition, owing to the ordered distribution of axons that compose WM and the development of new analytical techniques, computational resources and image analyses methodologies, geometrical reconstruction of the WM’s detailed microstructure becomes feasible by programming [21, 22]. Therefore, in this paper, a microstructural model of WM is reconstructed to mimic the microenvironment of brain tissue, where the NPs transport occurs. A mathematical model is also built to trace the trajectory of every single particle in this realistic virtual prototype of WM, the result of which can be used to calculate the D of NPs [23]. Based on this framework, both independent and coupling effects of NP’s size and Zp on its D are investigated, which can be used to improve our ability to design NPs for the treatment of brain diseases.

 

Friday, March 25, 2022

Distant Regions of the Human Brain Are Wired Together by Surprisingly Few Connections

It is your doctor's responsibility to objectively know the damage to both the gray matter and the white matter in your brain. Without that knowledge your doctor is totally guessing what needs to be done to get you recovered.   Which might explain those doctors who prescribe E.T.(Evaluate and Treat) to the therapists. They know nothing about stroke rehab so they are punting responsibility to the therapists. From this research it seems imperative your doctor knows EXACTLY how to initiate axon pathfinding, neurite outgrowth and dendritic branching.

And if your doctor knows nothing about semaphorins you don't have a stroke doctor.

RUN AWAY!

Semaphorins and their Signaling Mechanisms January 2018

From there: 

Early studies revealed that semaphorins function as axon guidance molecules,(We need this to have our white matter do the connections needed.)

 

 Distant Regions of the Human Brain Are Wired Together by Surprisingly Few Connections

Summary: Study reveals axon density is lower than previously believed between distant regions of the brain.

Source: PLOS

Understanding how the brain functions, particularly how information is processed during different activities, is difficult without knowing how many axons are in the brain and how many connect different functional regions.

An approach by Burke Rosen and Eric Halgren at the University of California, San Diego, U.S. published March 24 in the open-access journal PLOS Biology, shows that despite the functional importance of connections between far-reaching regions of the brain, the actual number of these connections is low.

In the new study, researchers combined diffusion MRI data from the Human Connectome Project with histological cross-sections of the corpus callosum, the major tract that connects the left and right sides of the brain.

The Human Connectome maps the strength of all connections in the brain but does not provide the actual number of axons, while the histological cross-sections allow estimates for how many axons are packed into a given volume.

Combining the connection strengths with the axon densities yielded estimates for the number of axons in the cerebral cortex.

The analysis indicated that there are almost 2.5 billion long-range axons traversing the cerebral cortex.

This shows brain scans
The number of axons estimated to interconnect the 360 cortical parcels of the HCP-MMP1.0 atlas. Credit: The researchers

However, despite this large number, they found that the numbers connecting different functional brain regions were quite low. For example, among the estimated 130 million axons in the arcuate fasciculus tract, only about 1 to 2 million (less than 2%) directly connected Broca’s and Wernicke’s areas, a connection that is necessary for normal language ability.

The model predicts that other long connections, like those from the hippocampus to the frontal cortex that are needed for memory retrieval, are actually made in multiple steps.

The findings will thus improve models of cognition, especially processes that rely on connections between distal regions of the brain.

“A major unsolved problem is how the human cortex integrates information processing by its 16 billion neurons(Isn't it 80 billion?) across its surface to unify awareness,” Rosen adds.

“Our finding that cortical areas are sparsely connected implies that this integration is accomplished either via linkage of the dense local connections or by rare, extraordinarily privileged long-range axons.”

About this neuroscience research news

Author: Press Office
Source: PLOS
Contact: Press Office – PLOS
Image: The image is credited to the researchers

Original Research: Open access.
“An estimation of the absolute number of axons indicates that human cortical areas are sparsely connected” by Burke Q. Rosen et al. PLOS Biology

 

Thursday, May 13, 2021

Semaphorins in Adult Nervous System Plasticity and Disease

 You can see that semaphorins have been researched for years in stroke but obviously  since we have NO LEADERSHIP AND NO STRATEGY nothing useful for stroke recovery has occurred with all this research. Leaders would solve stroke, not let it fester for decades.


Semaphorins and their Signaling Mechanisms January 2018

From there: 

Early studies revealed that semaphorins function as axon guidance molecules,(We need this to have our white matter do the connections needed.) but it is now understood that semaphorins are key regulators of morphology and motility in many different cell types including those that make up the nervous, cardiovascular, immune, endocrine, hepatic, renal, reproductive, respiratory and musculoskeletal systems, as well as in cancer cells.

 

Astrocyte-Derived Exosomes Treated With a Semaphorin 3A Inhibitor Enhance Stroke Recovery via Prostaglandin D2 Synthase September 2018

 

Following experimental stroke, the recovering brain is vulnerable to lipoxygenase‐dependent semaphorin signaling  October 2012

Serum semaphorin 7A is associated with the risk of acute atherothrombotic stroke  February 2019

Use of semaphorin-4D binding molecules to promote neurogenesis following stroke  May 2012

Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A  June 2011

Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery  February 2008

 

Cellular and molecular mechanisms of neural repair after stroke: making waves April 2006

The latest here:

Semaphorins in Adult Nervous System Plasticity and Disease

  • 1Laboratory for Neuroregeneration, Netherlands Institute for Neuroscience, Royal Academy of Arts and Sciences, Amsterdam, Netherlands
  • 2Department of Neuroscience Rita Levi-Montalcini and Neuroscience Institute Cavalieri Ottolenghi, University of Turin, Turin, Italy

Semaphorins, originally discovered as guidance cues for developing axons, are involved in many processes that shape the nervous system during development, from neuronal proliferation and migration to neuritogenesis and synapse formation. Interestingly, the expression of many Semaphorins persists after development. For instance, Semaphorin 3A is a component of perineuronal nets, the extracellular matrix structures enwrapping certain types of neurons in the adult CNS, which contribute to the closure of the critical period for plasticity. Semaphorin 3G and 4C play a crucial role in the control of adult hippocampal connectivity and memory processes, and Semaphorin 5A and 7A regulate adult neurogenesis. This evidence points to a role of Semaphorins in the regulation of adult neuronal plasticity. In this review, we address the distribution of Semaphorins in the adult nervous system and we discuss their function in physiological and pathological processes.

Introduction

The development of complex tissues depends on proliferation, differentiation and migration of cells. Cell guidance cues regulate these events and continue to be essential throughout life to maintain tissue homeostasis. Semaphorins constitute a large family of cell guidance cues, which are present in some viruses and conserved across animal species, from worms and flies to humans. Thirty Semaphorin proteins have been identified so far. They can be divided into eight classes (Sema1-7 and the viral Semaphorins, SemaV) on the basis of phylogenetic relationships and structural features. Sema1, Sema2, and Sema5C are found in invertebrates, whereas all the other Semaphorin classes are found in vertebrates (Bamberg et al., 1999; Pasterkamp, 2012; Alto and Terman, 2017; Figure 1). Semaphorins can be secreted (Sema2, Sema3, and SemaV), membrane-spanning (Sema1, Sema4, Sema5, and Sema6) or glycosylphosphatidylinositol-anchored (Sema7A). The structural hallmark of the Semaphorin protein family is an extracellular domain at the N-terminal region, important for dimerization and interaction specificity, called Sema domain, which is followed by a Plxn–Semaphorin–integrin domain and by distinct protein domains that further define Semaphorins (Zhou et al., 2008; Figure 1).

FIGURE 1
www.frontiersin.org

Figure 1. Semaphorins and their receptors. Semaphorins can be categorized into eight classes. Viral Sema is found in the genomes of certain DNA viruses; Sema1, Sema2, and Sema5c comprise the invertebrate Semaphorins; the other Semaphorin classes are found in vertebrates. Semaphorins are secreted (viral Sema, Sema2, and Sema3), membrane-spanning (Sema1, Sema4, Sema5, and Sema6) or glycosylphosphatidylinositol-anchored proteins (Sema7A). Semaphorins bind to Plxn receptors (PlxnA1–PlxnA4, PlxnB1–PlxnB3, PlxnC1, and PlxnD1) – see arrows for specific interactions. Sema3 require Npn for binding to PlxnA.

First characterized by their ability to act as repulsive cues for growing neurites (Kolodkin et al., 1992, 1993; Luo et al., 1993), Semaphorins are now known to be crucial molecules also for the development and functioning of the musculoskeletal, cardiovascular, respiratory, immune, endocrine, reproductive, hepatic, and renal system. In addition, Semaphorin signaling has been linked to diseases affecting these systems, as well as to cancer (Roth et al., 2009; Neufeld et al., 2012; Pasterkamp, 2012; Tamagnone, 2012; Giacobini and Prevot, 2013; Kang and Kumanogoh, 2013; Kumanogoh and Kikutani, 2013).

The effects of Semaphorins occur through binding to their receptors, the neuropilin (Npn) and plexin (Plxn) protein families (Figure 1). Plxns are grouped in four classes, from A to D, with four A-type, three B-type, one C-type and one D-type. The Plxn extracellular region contains several sema domains, which are important for binding to Semaphorins, whereas the intracellular region contains GTPase-activating protein domains (Takahashi et al., 1999; Tamagnone et al., 1999). In general, Semaphorins exist as homodimers, both in an unbound state and when interacting with Plxns. Semaphorin homodimers bring together two Plxn monomers or disrupt existing Plxn homodimers, relieving Plxn autoinhibition, which might be caused by an interaction between the sema domain of Plxn and the rest of the Plxn extracellular domain (Takahashi and Strittmatter, 2001; Kong et al., 2016). Once activated, Plxn signals through downstream molecules, including GTPases of the Rho family, protein kinases such as MAPK, and enzymes such as MICAL (molecule interacting with casL), which induce the phosphorylation of intracellular proteins of the collapsin responsive mediator protein (CRMP) family (Vikis et al., 2000; Hu et al., 2001; Liu and Strittmatter, 2001; Terman et al., 2002; Pasterkamp et al., 2003; Hota and Buck, 2012). CRMPs, in turn, affect actin and microtubule dynamics (Hung et al., 2010, 2011; Alto and Terman, 2017). Membrane-associated Semaphorins can also act as receptors or co-receptors for Semaphorins located on other cells, a phenomenon known as reverse signaling (Battistini and Tamagnone, 2016).

Class 3 Semaphorins require Npn as co-receptors (Npn-1 and -2). Npn-1 homodimers function as ligand-binding receptors for Sema3A and Sema3D; Npn-2 homodimers as receptors for Sema3F; and Npn-1 and Npn-2 heterodimers as receptors for Sema3B, 3C, 3E, and 3G (He et al., 2019; Toledano et al., 2019). Npn are transmembrane proteins with short intracellular domains that lack intrinsic enzymatic or signaling activity. They do not seem to act as a direct bridge between Plxn and Semaphorins but may function in the presentation of Semaphorin to Plxn. In addition, Npn can bind vascular endothelial growth factor (VEGF) in co-receptor complexes with VEGF receptors (Kruger et al., 2005; Pasterkamp, 2012), regulating blood and lymphatic vessel growth (Tammela et al., 2005).

Additional receptors can directly bind Semaphorins, including CD72 (Kumanogoh et al., 2000), Tim2 (Kumanogoh et al., 2002), and integrins (Pasterkamp et al., 2003). Moreover, co-receptors that associate with Sema binding receptors affect the signaling outcome of Sema-receptor interactions (Sharma et al., 2012). Cell adhesion molecules, such as Nr-CAM and L1 CAM can associate with Npn receptors and can be required for transducing class 3 Sema signals (Castellani et al., 2000, 2004; Falk et al., 2005). In addition, a number of receptor tyrosine kinases, such as VEGF receptor 2, Met, ErbB2 and off-track, associate with Plxns and Npns and become transactivated upon Sema binding (Sharma et al., 2012). Interestingly, Semaphorin function can be modulated by binding to proteoglycans (Kantor et al., 2004; de Wit et al., 2005; Zimmer et al., 2010; Cho et al., 2012; Dick et al., 2013). For example, class 5 Semaphorins demonstrate axon repulsive properties on neurites that co-express chondroitin sulfate proteoglycans and Plxns, while they turn into attractive cues if neurites express heparan sulfate proteoglycans adjacent to Plxns (Kantor et al., 2004).

Semaphorins have been discovered in the early 1990s as repulsive axon guidance molecules, enabling axons to find their targets and thus contributing to nervous system development (Kolodkin et al., 1992, 1993; Luo et al., 1993). In the peripheral nervous system, Semaphorins of several classes form molecular boundaries to prevent axons of dorsal root ganglion neurons, cranial nerves, spinal motoneurons or sympathetic neurons from entering inappropriate areas (Masuda and Taniguchi, 2016). Repulsive Semaphorin signaling is also crucial in the control of axon pathfinding of several classes of central nervous system (CNS) neurons during development (Sahay et al., 2003; Kolk et al., 2009; Pignata et al., 2016; Alto and Terman, 2017; Okada et al., 2019). The main mechanism how Semaphorins act as guidance molecules is through activation of Plxn signaling, which induces cytoskeletal changes in the growth cone of developing axons, such as depolymerization of actin filaments, attenuation of microtubule dynamics, and collapse of microtubule arrays (Goshima et al., 1997; Fritsche et al., 1999; Hung et al., 2010).

In the last three decades, Semaphorins have been shown to be involved in many other developmental processes that shape the nervous system, including axon defasciculation (Kolodkin et al., 1992; Tran et al., 2007; Claudepierre et al., 2008; Pecho-Vrieseling et al., 2009; Imai, 2012; Assens et al., 2016), lamina-specific patterning of synaptic connectivity (Skutella and Nitsch, 2001; Pasterkamp, 2012; Xie et al., 2019), axon terminal branching (Bagnard et al., 1998; Bagri et al., 2003; Dent et al., 2004; Cioni et al., 2013; Jung et al., 2019), dendritic morphogenesis and arborization (Polleux et al., 2000; Fenstermaker et al., 2004; Vodrazka et al., 2009; Ng et al., 2013; Cheadle and Biederer, 2014; Yamashita et al., 2014; Danelon et al., 2020), synapse formation (Godenschwege et al., 2002; Morita et al., 2006; Paradis et al., 2007; Yamashita et al., 2007; Tran et al., 2009; Kuzirian et al., 2013; Inoue et al., 2018; McDermott et al., 2018), subcellular target recognition by specific axons (Telley et al., 2016), pruning (Bagri et al., 2003; Sahay et al., 2003; Faulkner et al., 2006; Low et al., 2008; Uesaka et al., 2014), and removal of ectopic synapses (O’Connor et al., 2009; Tran et al., 2009; Mohan et al., 2018, 2021).

Many excellent reviews have addressed the functions of Semaphorins during nervous system development. Here, we will provide an overview of the role of Semaphorins in adult CNS physiology and pathology, including the role of Sema3A in plasticity processes through its interaction with the extracellular matrix (ECM).

Semaphorins in Adult Nervous System Physiology

Semaphorins are found in the nervous system not only during development but also in adulthood. Early studies showed that Sema3A mRNA expression persists in several discrete areas of the adult CNS and PNS (Luo et al., 1993; Giger et al., 1996, 1998; Pasterkamp et al., 1998; de Wit and Verhaagen, 2003). Since then, the role of Sema3A and other Semaphorins in the physiology of the adult nervous system has been progressively unveiled, pointing to a role of these axon guidance cues in the regulation of neuroplasticity.

 More at link,